PCRX FY 2020 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$971M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$430M+2.0% YoY

Gross Profit

$312M72.7% margin

Operating Income

$46M10.8% margin

Net Income

$146M33.9% margin

EPS (Diluted)

$3.33

Cash Flow

Operating Cash Flow

$77M

Free Cash Flow

$39M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$655M

Stockholders' Equity

$620M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$430M	$421M	+2.0%
Gross Profit	$312M	$314M	-0.6%
Operating Income	$46M	$10M	+342.3%
Net Income	$146M	-$11M	+1421.0%